Snakebite Mitigation Project of the Madras Crocodile Bank/Centre for Herpetology, India: background and a brief summary of activities

2018 ◽  
Vol 113 (12) ◽  
pp. 818-819
Author(s):  
Romulus Whitaker

Abstract Snakebite is a serious problem in rural India where several highly venomous species are commonly found in and around agricultural areas where prey such as rodents and amphibians are abundant. Four snake species, referred to as the Big Four, are responsible for the most serious and fatal bites: spectacled cobra (Naja naja), Russell’s viper (Daboia russelii), common krait (Bungarus caeruleus) and saw-scaled viper (Echis carinatus). A polyvalent antivenom is made to treat these bites but public awareness and distribution of this life-saving drug is inadequate. The Madras Crocodile Bank and its partners are conducting a snakebite project which includes venom sampling and research, snake and snakebite treatment centre mapping, and a nationwide awareness campaign for snakebite mitigation.

2009 ◽  
Vol 3 (6) ◽  
pp. 1516-1520 ◽  
Author(s):  
May M. Cheng

It is no longer possible to identify counterfeit medical products, including medications and devices, by simply checking packaging and labeling. Improvements in technology have made it cheaper and easier to produce fake packaging and labels, making it nearly impossible for consumers and authorities to detect counterfeits without conducting tests on the products themselves, as illustrated by the sale of over one million counterfeit blood glucose test strips sold to unsuspecting U.S. consumers at drugstores in more than 35 states and in other countries around the world in the fall of 2006. The pricier the drugs, the more counterfeiters seek to mimic them to maximize returns, victimizing those patients at highest risk who rely on life-saving medications. The interconnected global economy and advances in technology that benefit legitimate businesses and consumers is also benefiting counterfeiters. As pharmaceutical and medical device companies use new technologies and work with governments and international agencies to combat counterfeiting on a global scale, a public awareness campaign is needed to educate consumers to protect themselves.


2021 ◽  
Vol 147 ◽  
pp. 106522
Author(s):  
Stephanie Van Asbroeck ◽  
Martin P.J. van Boxtel ◽  
Jan Steyaert ◽  
Sebastian Köhler ◽  
Irene Heger ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Mohammed Hamad Aldebasi ◽  
Nasser Abdalazez Alsobaie ◽  
Abdulrahman Yousef Aldayel ◽  
Khalid Mousa Alwusaidi ◽  
Tariq Alasbali

Awareness of the patients to the differences between ophthalmologists and optometrists has been recognized as an important factor influencing patient utilization of available eye care services. This study aimed at assessing the public’s knowledge of the differences between ophthalmologists and optometrists among the residents of Riyadh, Saudi Arabia. An online questionnaire was administered to adults in Riyadh, Saudi Arabia, from January to February in 2018. The number of the respondents was 1579. Results show that 50% (n=789) of the participants had fair knowledge of the differences between ophthalmologists and optometrists, while 32% (n=505) had poor knowledge. After multivariate logistic regression analysis, there was a significant association between satisfactory knowledge and visiting an optometrist (odds ratio (OR): 0.75, 95% CI: 0.57–0.98), age older than 26 (OR: 1.73, 95% CI: 1.17–1.19), higher level of education (OR: 1.92, 95% CI: 1.54–2.4), and wearing spectacles (OR: 0.57, 95% CI: 0.45–0.73). Given the low level of public knowledge regarding the differences in the duties between ophthalmologist and optometrists among a Saudi population, there is great potential for general population education through awareness campaign and social media regarding eye care provider’s duties and practices.


2019 ◽  
Vol 13 (2) ◽  
pp. 272 ◽  
Author(s):  
Philip Russell

‘Be Media Smart’ is an Irish public awareness campaign calling on people of all ages to ‘Be Media Smart’ and ‘Stop, Think, and Check’ that information they see, read or hear across any media platform is accurate and reliable. This national media literacy campaign was aimed at enhancing people’s understanding of, and engagement with, media, while also empowering them with the skills to evaluate content across all platforms.


Global Heart ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e127
Author(s):  
G. Devlin ◽  
G. Williams ◽  
T. Duncan ◽  
F. Hamilton ◽  
S. DeSilva ◽  
...  

2019 ◽  
Vol 3 (4) ◽  
pp. 190-198
Author(s):  
Rebecca N. Jerome ◽  
Leah Dunkel ◽  
Nan Kennedy ◽  
Erik J. Olson ◽  
Jill M. Pulley ◽  
...  

AbstractIntroduction:Individuals experiencing different medical conditions, as well as healthy volunteers, may often be interested in trial participation, and researchers similarly need to find participants to advance medical knowledge. The ResearchMatch (RM) Trials Today clinical trial searching tool leverages clinicaltrials.gov data to enable potential participants to look for trial opportunities relevant to their situation. To facilitate expanded use of this tool, we undertook a national digital public awareness campaign to increase awareness of Trials Today among members of the general public.Methods:The awareness campaign promoted Trials Today using Facebook and digital banner messages in 2017, encompassing nine cities across the USA. The digital strategy was complemented by print media in several outlets. We employed descriptive statistics to summarize campaign metrics and site usage data during the campaign.Results:The campaign was successful in increasing visits to Trials Today, with 142,303 sessions logged during its run, as compared to pre-campaign data indicating 104,688 total sessions during the entire 2-year period since the site’s inception. The city-specific click-through rate for all digital impressions, combining Facebook and banner messaging, ranged from 0.50% to 1.09%, resulting in a cost-per-click range of $0.69–$1.15. In addition, visitors conducted 29,697 searches and viewed individual trial records 173,512 times.Conclusion:The public awareness campaign was successful in increasing use of the RM Trials Today clinical trial searching tool. Our findings support the value of digital media messaging as a cost-effective vehicle for promoting clinical trial awareness, especially for chronic ailments.


Sign in / Sign up

Export Citation Format

Share Document